MENU
SAVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cassava Sciences (SAVA) Earnings Date & Reports

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease... Show more

A.I. Advisor
published Earnings

SAVA is expected to report earnings to fall 52.63% to -27 cents per share on March 03

Cassava Sciences SAVA Stock Earnings Reports
Q4'25
Est.
$-0.27
Q4'24
Missed
by $0.09
Q3'24
Beat
by $0.15
Q2'24
Beat
by $0.54
Q1'24
Beat
by $0.03
The last earnings report on March 03 showed earnings per share of -56 cents, missing the estimate of -47 cents. With 762.08K shares outstanding, the current market capitalization sits at 132.85M.
View a ticker or compare two or three
SAVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SAVA showed earnings on March 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of novel drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
6801 N. Capital of Texas Highway
Phone
+1 512 501-2444
Employees
29
Web
https://www.cassavasciences.com